NEW YORK – Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall
1 year ago
COPENHAGEN – Novo Nordisk’s (NYSE: NVO) Pharmatech unit will build a 1.5 billion Danish crown ($221 million) plant in Denmark
2 years ago
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) posted second-quarter operating profit below expectations, raised its 2024 sales forecast but
LONDON/WASHINGTON – Novo Nordisk’s (NYSE: NVO) decision to stop selling its long-acting insulin Levemir in the United States has left
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)
On Friday, the U.S. Food and Drug Administration warned patients and doctors about dosing errors associated with compounded versions of
AMSTERDAM/COPENHAGEN – Danish drugmaker Novo Nordisk (NYSE: NVO) said on Wednesday it was disappointed with the recommendation to the Netherlands
LONDON – Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder
WASHINGTON – Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk (NYSE: NVO) can be convinced to cut the
Only one in four U.S. patients prescribed Novo Nordisk’s (NYSE: NVO) Wegovy or Ozempic for weight loss were still taking
